RefleXion (Biotechnology) Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
260
- Latest Deal Type
-
Series F
- Latest Deal Amount
-
$107M
- Investors
-
20
RefleXion (Biotechnology) General Information
Description
Developer of a biology-guided radiotherapy designed to create a new cancer treatment modality. The company's radiotherapy leverages positron emission tomography (PET) in a novel way and combines it with stereotactic radiotherapy for superior localization and tumor tracking at the time of treatment delivery, enabling physicians to reveal cancer cell location and then destroy it.
Contact Information
Website
www.reflexion.comCorporate Office
- 25841 Industrial Boulevard
- Suite 275
- Hayward, CA 94545
- United States
Corporate Office
- 25841 Industrial Boulevard
- Suite 275
- Hayward, CA 94545
- United States
RefleXion (Biotechnology) Timeline
RefleXion (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC (Series F) | 15-Nov-2023 | $107M | Completed | Generating Revenue | ||
| 10. Debt Refinancing | 12-Jul-2022 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series E) | 16-Mar-2022 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series D1) | Completed | Generating Revenue | ||||
| 7. Later Stage VC (Series D) | 16-Apr-2020 | Completed | Generating Revenue | |||
| 6. General Corporate Purpose | 08-May-2019 | Completed | Generating Revenue | |||
| 5. Grant | 01-Jan-2019 | Completed | Generating Revenue | |||
| 4. Grant | 06-Apr-2018 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 04-Apr-2018 | $100M | $164M | Completed | Generating Revenue | |
| 2. Later Stage VC (Series B) | 19-Jul-2016 | $52M | $63.6M | Completed | Generating Revenue |
RefleXion (Biotechnology) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series F | ||||||||
| Series E-X | ||||||||
| Series E | ||||||||
| Series D-1-X | ||||||||
| Series D-1 | ||||||||
| Series D-X | ||||||||
| Series D | ||||||||
| Series C-X | ||||||||
| Series C | 60,639,366 | $0.001000 | $0.14 | $1.69 | $1.69 | 1x | $1.31 | 9.01% |
| Series B-X | 48,199,870 | $0.001000 | $0.09 | $1.08 | $1.08 | 1x | $1.08 | 5.53% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
RefleXion (Biotechnology) Comparisons
Industry
Financing
Details
RefleXion (Biotechnology) Competitors (14)
One of RefleXion (Biotechnology)’s 14 competitors is ExCellThera, a Accelerator/Incubator Backed company based in Montreal, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ExCellThera | Accelerator/Incubator Backed | Montreal, Canada | ||||
| P-Cure | Venture Capital-Backed | Shilat, Israel | ||||
| ZAP Surgical | Venture Capital-Backed | San Carlos, CA | ||||
| CivaTech Oncology | Venture Capital-Backed | Durham, NC | ||||
| AsherBio | Venture Capital-Backed | South San Francisco, CA |
RefleXion (Biotechnology) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
RefleXion (Biotechnology) Patents
RefleXion (Biotechnology) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4486682-A2 | Service cranes for medical systems | Pending | 03-Mar-2022 | ||
| US-20230201629-A1 | Methods for radiation delivery quality assurance | Pending | 27-Dec-2021 | ||
| EP-4456978-A1 | Methods for radiation delivery quality assurance | Pending | 27-Dec-2021 | ||
| EP-4426425-A1 | Radiotherapy systems and methods for quality assurance and calibration | Pending | 03-Nov-2021 | ||
| US-20240359036-A1 | Radiotherapy systems and methods for quality assurance and calibration | Pending | 03-Nov-2021 | A61N5/1071 |
RefleXion (Biotechnology) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
RefleXion (Biotechnology) Investors (20)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ascension Ventures | Corporate Venture Capital | Minority | ||
| Catalio Capital Management | Venture Capital | Minority | ||
| Hillenbrand Capital Partners | Venture Capital | Minority | ||
| Sixty Degree Capital | Venture Capital | Minority | ||
| Ally Bridge Group | PE/Buyout | Minority |
RefleXion (Biotechnology) FAQs
-
When was RefleXion (Biotechnology) founded?
RefleXion (Biotechnology) was founded in 2009.
-
Where is RefleXion (Biotechnology) headquartered?
RefleXion (Biotechnology) is headquartered in Hayward, CA.
-
What is the size of RefleXion (Biotechnology)?
RefleXion (Biotechnology) has 260 total employees.
-
What industry is RefleXion (Biotechnology) in?
RefleXion (Biotechnology)’s primary industry is Biotechnology.
-
Is RefleXion (Biotechnology) a private or public company?
RefleXion (Biotechnology) is a Private company.
-
What is the current valuation of RefleXion (Biotechnology)?
The current valuation of RefleXion (Biotechnology) is .
-
What is RefleXion (Biotechnology)’s current revenue?
The current revenue for RefleXion (Biotechnology) is .
-
How much funding has RefleXion (Biotechnology) raised over time?
RefleXion (Biotechnology) has raised $616M.
-
Who are RefleXion (Biotechnology)’s investors?
Ascension Ventures, Catalio Capital Management, Hillenbrand Capital Partners, Sixty Degree Capital, and Ally Bridge Group are 5 of 20 investors who have invested in RefleXion (Biotechnology).
-
Who are RefleXion (Biotechnology)’s competitors?
ExCellThera, P-Cure, ZAP Surgical, CivaTech Oncology, and AsherBio are some of the 14 competitors of RefleXion (Biotechnology).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
